Keywords
physiotherapy
rehabilitation
How to Cite
Abstract
Rehabilitative modalities such as incentive spirometry and physiotherapy interventions, e.g. aerobic exercises, have been shown to produce positive outcomes in patients with sickle cell disease (SCD). Hemispheric CVA and other complications arising from SCD are amenable to physiotherapy. There have been few studies on the effectiveness of physiotherapy in the management of individuals with SCD. The present study attempts to assess the SCD-related knowledge, attitude and level of participation of physiotherapists in the Nigerian healthcare system. It also examines a possible association between the foregoing and practice settings. The study was carried out among physiotherapists in South-West Nigeria registered on professional e-platforms. The respondents filled in an adapted electronic version of a questionnaire. The IBM SPSS 20 was used for statistical analysis, and a chi-square test was used to determine an association between the levels of knowledge, practice settings, and participation among the respondents (p < 0.05). The study findings revealed that only 19% of respondents had received a specific training related to the care of SCD patients, although 65% had been involved in the treatment of at least one patient with SCD. Only 29.5% of respondents had “Good Knowledge” of SCD pathophysiology. A statistically significant association (χ2 = 75.357, p = 0.012) was found between respondents’ level of knowledge and their practice settings, i.e. a teaching hospital mostly. The physiotherapists from the Nigerian South-West,
mostly those working in teaching hospitals, reported an average level of knowledge of SCD care. Since the management of sickle cell disease is of multidisciplinary character and requires an all hands-on deck approach, controlled trials should be undertaken by physiotherapy researchers regarding the effects of modalities and interventions on pro-inflammatory bio-molecules.
References
Adegoke S. A., Kuteyi E. A. Psychosocial burden of sickle cell disease on the family, Nigeria. African Journal of Primary Health Care & Family Medicine 2012; 4(1): 380.
World Health Organization Sickle-Cell Anaemia Report by the Secretariat. Fifty-Ninth World Health Assembly [homepage]. C 2006 [cited 2011 Aug 18]. Available from http://apps.who.int/gb/ebwha/pdf_files/WHA59/A59_9-en.pdf.
Wilson M., Forsyth P., Whiteside J. Haemoglobinopathy and sickle cell disease. Continuing Education in Anaesthesia, Critical Care & Pain 2010; 10(1): 24–28.
Glynou K., Kastanis P., Boukouvala S., Tsaoussis V., Ioannou P. C., Christopoulos T. K., Traeger-Synodinos J., Kanavakis E. High-throughput microtiter well-based chemiluminometric genotyping of 15 HBB gene mutations in a dry-reagent format. Clinical Chemistry 2007; 53(3): 384–391.
Dalibalta S., Ellory J. C., Browning J. A., Wilkins R. J., Rees D. C., Gibson J. S. Novel permeability characteristics of red blood cells from sickle cell patients heterozygous for HbS and HbC (HbSCgenotype). Blood Cells, Molecules, and Diseases 2010; 45(1): 46–52.
Kato G. J., Piel F. B., Reid C. D., Gaston M. H., Ohene-Frempong K., Krishnamurti L., Smith W. R., Panepinto J. A., Weatherall D. J., Costa F. F., Vichinsky E. P. Sickle cell disease. Nature Reviews Disease Primers 2018; 4(1): 1–22.
Adekile A. D. Haemoglobinopathies. In: Azubuike J. C., Nkanginieme K. E. O. (eds.). Paediatrics and Child Health in a Tropical Region Owerri. Africana Educational Services 1999: 194–213.
Rees D. C., Olujohungbe A. D., Parker N. E., Stephens A. D., Telfer P., Wright J. British Committee for Standards in Haematology General Haematology Task Force by the Sickle Cell Working Party. Guidelines for the management of the acute painful crisis in sickle cell disease. British Journal of Haematology 2003; 120(5): 744–752.
Merlet A. N., Messonnier L. A., Coudy-Gandilhon C., Béchet D., Gellen B., Rupp T., Galactéros F., Bartolucci P., Féasson, L. Beneficial effects of endurance exercise training on skeletal muscle microvasculature in sickle cell disease patients. Blood 2019; 134(25): 2233–2241.
Gellen B., Messonnier L. A., Galactéros F., Audureau E., Merlet A. N., Rupp T., Peyrot S., Martin C., Féasson L., Bartolucci P., EXDRE collaborative study group Moderate-intensity enduranceexercise training in patients with sickle-cell disease without severe chronic complications (EXDRE): an open-label randomised controlled trial. The Lancet Haematology 2018; 5(11): e554–e562.
Messonnier L. A., Gellen B., Lacroix R., Peyrot S., Rupp T., Mira J., Peyrard A., Berkenou J., Galactéros F., Bartolucci P., Féasson L. Physiological evaluation for endurance exercise prescription in sickle cell disease. Medicine and Science in Sports and Exercise 2019; 51(9): 1795–1801.
Adegoke B. O. A., Akinola O. A., Oyeyemi, L. A. Effects of 12-week aerobic dance on hematological variables and health status of individuals with sickle cell anaemia. Physiotherapy 2015; 101: e34.
Pal S., Dixit R., Moe S., Godinho M. A., Abas A. B., Ballas S. K., Ram S., Yousuf U. M. Transcutaneous electrical nerve stimulation (TENS) for pain management in sickle cell disease. Cochrane Database of Systematic Reviews 2020; 3: CD012762.
Bellet P. S., Kalinyak K. A., Shukla R., Gelfand M. J., Rucknagel D. L. Incentive spirometry to prevent acute pulmonary complications in sickle cell diseases. New England Journal of Medicine 1995; 333(11): 699–703.
Aliyu S. U., Rufa’I A. A., Saidu I. A., Jajere A. M. Musculoskeletal complications in sickle cell anemia patients: a ten-year retrospective review of hospital-based records (1991-2000) in two Nigerian hospitals. International Journal of Contemporary Pediatrics 2015; 2: 329–334.
Mbada C. E., Onigbinde O. A., Binuyo O. T., Ademoyegun A. B., Fatoye C. T., Idowu O. A., Ojoawo A. O., Oke K. I., Okafor U. A. C., Ojukwu C. P., Odole A., Fatoye F. Assessment of nigerian physiotherapy students’ knowledge, attitudes and awareness of physiotherapy roles in the prevention and management of COVID-19: A nationwide online survey. Journal of Physical Education & Health 2020; 9(15): 18–27.
Onyeso O. K., Umunnah J. O., Ezema C. I., Anyachukwu C. C., Nwankwo M. J., Odole A. C., Oke K. I., Bello B. Profile of practitioners, and factors influencing home care physiotherapy model of practice in Nigeria. Home Health Care Services Quarterly 2020; 39(3): 168–183.
Connolly M. E., Bills S. E., Hardy S. J. Neurocognitive and psychological effects of persistent pain in pediatric sickle cell disease. Pediatric Blood & Cancer 2019; 66(9): e27823.
Shah N., Bhor M., Xie L., Paulose J., Yuce H. (2019). Sickle cell disease complications: Prevalence and resource utilization. PLoS One 14(7): e0214355.
Day M., Bonnet K., Schlundt D. G., DeBaun M., Sharma D. Vaso-occlusive pain and menstruation in sickle cell disease: a focus group analysis. Women's Health Reports 2020; 1(1): 36–46.
Kambasu D. M., Rujumba J., Lekuya H. M., Munube D., Mupere E. Health-related quality of life of adolescents with sickle cell disease in sub-Saharan Africa: a cross-sectional study. BMC Hematology 2019; 19(1): 1–9.
Tinti G., Somera R., Valente F. M., Domingos C. R. B. Benefits of kinesiotherapy and aquatic rehabilitation on sickle cell anemia. A case report. Genetics and Molecular Research 2010; 9(1): 360–364.
Zouki T., Haroutunian A., Malcolm T. Pain Management for the Sickle Cell Patient. In: Pain Management in Special Circumstances, 2018.
Okocha C., Onubogu C. U., Aneke J., Onah C., Ajuba I., Ibeh N., Egbuonu I. Prevalence of sickle cell gene among apparently healthy under-two South-East Nigerian children: What is the role of parental premarital counselling and socio-demographic characteristics? A pilot study. Nigerian Journal of Medicine 2016; 25(2): 176–181.
Monfort J. B., Senet P. Leg ulcers in sickle-cell disease: treatment update. Advances in Wound Care 2020; 9(6): 348–356.
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Copyright (c) 2021 Array